Transforming Growth Factor Beta 1 Market Report

Global and Region Transforming Growth Factor Beta 1 Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：154
  • REPORT CODE：GMM888342
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Transforming Growth Factor Beta 1 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Transforming Growth Factor Beta 1market, defines the market attractiveness level of Transforming Growth Factor Beta 1 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Transforming Growth Factor Beta 1 industry, describes the types of Transforming Growth Factor Beta 1 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Transforming Growth Factor Beta 1 market and the development prospects and opportunities of Transforming Growth Factor Beta 1 industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Transforming Growth Factor Beta 1 market in Chapter 13.

    By Player:

    • Huabo Biopharm Co Ltd

    • Genzyme Corp

    • Sirnaomics Inc

    • Johnson & Johnson

    • Scholar Rock Inc

    • Isarna Therapeutics GmbH

    • Eli Lilly and Co

    • Novartis AG

    • Ensol Biosciences Inc

    • Acceleron Pharma Inc

    • Formation Biologics Inc

    By Type:

    • AVID-200

    • Decorin

    • Engedi-1000

    • Fresolimumab

    • Others

    By End-User:

    • Osteoarthritis

    • Acute Pain

    • Autoimmune Disorders

    • Breast Cancer

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Transforming Growth Factor Beta 1 Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Transforming Growth Factor Beta 1 Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Transforming Growth Factor Beta 1 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Transforming Growth Factor Beta 1 Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Transforming Growth Factor Beta 1 Market Analysis and Outlook to 2022

    • 7.1 Global Transforming Growth Factor Beta 1 Consumption (2017-2022)

    • 7.2 United States Transforming Growth Factor Beta 1 Consumption (2017-2022)

    • 7.3 Europe Transforming Growth Factor Beta 1 Consumption (2017-2022)

    • 7.4 China Transforming Growth Factor Beta 1 Consumption (2017-2022)

    • 7.5 Japan Transforming Growth Factor Beta 1 Consumption (2017-2022)

    • 7.6 India Transforming Growth Factor Beta 1 Consumption (2017-2022)

    • 7.7 South Korea Transforming Growth Factor Beta 1 Consumption (2017-2022)

    8 Region and Country-wise Transforming Growth Factor Beta 1 Market Analysis and Outlook to 2028

    • 8.1 Global Transforming Growth Factor Beta 1 Consumption Forecast (2022-2028)

    • 8.2 United States Transforming Growth Factor Beta 1 Consumption Forecast (2022-2028)

    • 8.3 Europe Transforming Growth Factor Beta 1 Consumption Forecast (2022-2028)

    • 8.4 China Transforming Growth Factor Beta 1 Consumption Forecast (2022-2028)

    • 8.5 Japan Transforming Growth Factor Beta 1 Consumption Forecast (2022-2028)

    • 8.6 India Transforming Growth Factor Beta 1 Consumption Forecast (2022-2028)

    • 8.7 South Korea Transforming Growth Factor Beta 1 Consumption Forecast (2022-2028)

    9 Global Transforming Growth Factor Beta 1 Market Outlook by Types and Applications to 2022

    • 9.1 Global Transforming Growth Factor Beta 1 Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global AVID-200 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Decorin Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Engedi-1000 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Fresolimumab Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Transforming Growth Factor Beta 1 Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Osteoarthritis Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Acute Pain Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Breast Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Transforming Growth Factor Beta 1 Market Outlook by Types and Applications to 2028

    • 10.1 Global Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global AVID-200 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Decorin Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Engedi-1000 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Fresolimumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Acute Pain Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Transforming Growth Factor Beta 1 Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Transforming Growth Factor Beta 1 Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Transforming Growth Factor Beta 1 Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Transforming Growth Factor Beta 1 Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Transforming Growth Factor Beta 1 Market Competitive Analysis

    • 14.1 Huabo Biopharm Co Ltd

      • 14.1.1 Huabo Biopharm Co Ltd Company Details

      • 14.1.2 Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Product and Service

    • 14.2 Genzyme Corp

      • 14.2.1 Genzyme Corp Company Details

      • 14.2.2 Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Genzyme Corp Transforming Growth Factor Beta 1 Product and Service

    • 14.3 Sirnaomics Inc

      • 14.3.1 Sirnaomics Inc Company Details

      • 14.3.2 Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Sirnaomics Inc Transforming Growth Factor Beta 1 Product and Service

    • 14.4 Johnson & Johnson

      • 14.4.1 Johnson & Johnson Company Details

      • 14.4.2 Johnson & Johnson Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Johnson & Johnson Transforming Growth Factor Beta 1 Product and Service

    • 14.5 Scholar Rock Inc

      • 14.5.1 Scholar Rock Inc Company Details

      • 14.5.2 Scholar Rock Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Scholar Rock Inc Transforming Growth Factor Beta 1 Product and Service

    • 14.6 Isarna Therapeutics GmbH

      • 14.6.1 Isarna Therapeutics GmbH Company Details

      • 14.6.2 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product and Service

    • 14.7 Eli Lilly and Co

      • 14.7.1 Eli Lilly and Co Company Details

      • 14.7.2 Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Eli Lilly and Co Transforming Growth Factor Beta 1 Product and Service

    • 14.8 Novartis AG

      • 14.8.1 Novartis AG Company Details

      • 14.8.2 Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Novartis AG Transforming Growth Factor Beta 1 Product and Service

    • 14.9 Ensol Biosciences Inc

      • 14.9.1 Ensol Biosciences Inc Company Details

      • 14.9.2 Ensol Biosciences Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Ensol Biosciences Inc Transforming Growth Factor Beta 1 Product and Service

    • 14.10 Acceleron Pharma Inc

      • 14.10.1 Acceleron Pharma Inc Company Details

      • 14.10.2 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product and Service

    • 14.11 Formation Biologics Inc

      • 14.11.1 Formation Biologics Inc Company Details

      • 14.11.2 Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Formation Biologics Inc Transforming Growth Factor Beta 1 Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Transforming Growth Factor Beta 1

    • Figure Transforming Growth Factor Beta 1 Picture

    • Table Global Transforming Growth Factor Beta 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transforming Growth Factor Beta 1 Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Transforming Growth Factor Beta 1 Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Transforming Growth Factor Beta 1 Consumption by Country (2017-2022)

    • Figure United States Transforming Growth Factor Beta 1 Consumption and Growth Rate (2017-2022)

    • Table Europe Transforming Growth Factor Beta 1 Consumption and Growth Rate (2017-2022)

    • Figure China Transforming Growth Factor Beta 1 Consumption and Growth Rate (2017-2022)

    • Figure Japan Transforming Growth Factor Beta 1 Consumption and Growth Rate (2017-2022)

    • Figure India Transforming Growth Factor Beta 1 Consumption and Growth Rate (2017-2022)

    • Figure South Korea Transforming Growth Factor Beta 1 Consumption and Growth Rate (2017-2022)

    • Figure Global Transforming Growth Factor Beta 1 Consumption Forecast by Country (2022-2028)

    • Figure United States Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Transforming Growth Factor Beta 1 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AVID-200 Consumption and Growth Rate (2017-2022)

    • Figure Global Decorin Consumption and Growth Rate (2017-2022)

    • Figure Global Engedi-1000 Consumption and Growth Rate (2017-2022)

    • Figure Global Fresolimumab Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Osteoarthritis Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Pain Consumption and Growth Rate (2017-2022)

    • Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global AVID-200 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Decorin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Engedi-1000 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fresolimumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Osteoarthritis Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Pain Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Transforming Growth Factor Beta 1 Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Transforming Growth Factor Beta 1 Export by Region (Top 5 Countries) (2017-2028)

    • Table Huabo Biopharm Co Ltd (Foundation Year, Company Profile and etc.)

    • Table Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Huabo Biopharm Co Ltd Transforming Growth Factor Beta 1 Product and Service

    • Table Genzyme Corp (Foundation Year, Company Profile and etc.)

    • Table Genzyme Corp Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genzyme Corp Transforming Growth Factor Beta 1 Product and Service

    • Table Sirnaomics Inc (Foundation Year, Company Profile and etc.)

    • Table Sirnaomics Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sirnaomics Inc Transforming Growth Factor Beta 1 Product and Service

    • Table Johnson & Johnson (Foundation Year, Company Profile and etc.)

    • Table Johnson & Johnson Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Transforming Growth Factor Beta 1 Product and Service

    • Table Scholar Rock Inc (Foundation Year, Company Profile and etc.)

    • Table Scholar Rock Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Scholar Rock Inc Transforming Growth Factor Beta 1 Product and Service

    • Table Isarna Therapeutics GmbH (Foundation Year, Company Profile and etc.)

    • Table Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Isarna Therapeutics GmbH Transforming Growth Factor Beta 1 Product and Service

    • Table Eli Lilly and Co (Foundation Year, Company Profile and etc.)

    • Table Eli Lilly and Co Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Eli Lilly and Co Transforming Growth Factor Beta 1 Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Transforming Growth Factor Beta 1 Product and Service

    • Table Ensol Biosciences Inc (Foundation Year, Company Profile and etc.)

    • Table Ensol Biosciences Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ensol Biosciences Inc Transforming Growth Factor Beta 1 Product and Service

    • Table Acceleron Pharma Inc (Foundation Year, Company Profile and etc.)

    • Table Acceleron Pharma Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acceleron Pharma Inc Transforming Growth Factor Beta 1 Product and Service

    • Table Formation Biologics Inc (Foundation Year, Company Profile and etc.)

    • Table Formation Biologics Inc Transforming Growth Factor Beta 1 Sales, Price, Value and Gross Profit (2017-2022)

    • Table Formation Biologics Inc Transforming Growth Factor Beta 1 Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US